PPARG and Insulin resistance: In particular, PPAR-α and PPAR-γ, ligand-activated transcription factors, regulate glucose, fatty acid, and lipid metabolism, inflammation and, especially in the pathogenesis of obesity, hypercholesterolemia, insulin resistance, and atherosclerosis [65].